In a new paper, researchers describe cell and animal studies that demonstrate how lipid modifications of remdesivir nucleoside can improve drug delivery, effectiveness and toxicity compared to remdesivir.
Click here for original story, Rethinking remdesivir: Researchers modify current drug, creating oral version that can be taken earlier in COVID-19 diagnoses
Source: ScienceDaily